Back to search

United Kingdom· GB-APID-40917811000001109

Deferasirox 360mg tablets

A deferasirox product containing deferasirox, registered in United Kingdom by Torrent Pharma (UK) Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC V03AC03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDeferasirox 360mg tabletsATCV03AC03REGISTER NO.GB-APID-4091781100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Deferasirox is registered in 18 of 19 countries.

Countries holding a registration under ATC V03AC03 (deferasirox), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Deferasirox · ATC V03AC03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deferasirox costs, country by country.

Normalised to the WHO defined daily dose (0.98 g), the median price runs from $24.11 in Spain to $59.57 in Switzerland — a ×2.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Deferasirox · price per daily dose (0.98 g)

USD · FX 28 Sept 2026

  • CH Switzerland$59.57
  • IT Italy$43.21
  • FR France$27.16
  • ES Spain$24.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Deferasirox
Manufacturer
Torrent Pharma (UK) Ltd
Country
United Kingdom (GB)
ATC code
V03AC03
ATC class
Deferasirox
Defined daily dose
0.98 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5060623372767
  • gtin
    05060623372767

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

616 interactions on record for deferasirox.

Graded by severity as the source publishes them — 205 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Deferasirox · interactions on record

616 records

  • 205 severe
  • 399 moderate
  • 12 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deferasirox in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deferasirox products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Deferasirox G.L., Deferasirox Ratiopharm
  • Belgium · Deferasirox Ab, Deferasirox Ab Ab
  • Bulgaria · Deferasirox Synthon, Ziadex
  • Cyprus · Deferasirox Msn, Issoferrol
  • Czechia · Deferasirox Auxpharma, Deferasirox Glenmark
  • Germany · Deferasi Puren, Deferasirox Abdi
  • Denmark · Deferasirox Deferasirox "jubilant", Deferasirox Glenmark
  • Spain · Deferasirox Abdi, Deferasirox Aurovitas
  • Finland · Deferasirox Glenmark, Deferasirox Stada
  • France · Deferasirox Arrow, Deferasirox Bgr
  • Greece · Deferasirox Pharmathen, Deferasirox Rafarm
  • Croatia · Deferasiroks Pliva, Deferasiroks Umedica
  • Hungary · Deferasirox Msn, Deferasirox Pharmascience
  • Iceland · Deferasirox Accord, Deferasirox Medical Valley
  • Italy · Deferasirox Abdi, Deferasirox Aurobindo
  • Liechtenstein · Deferasirox Accord, Deferasirox Mylan
  • Latvia · Deferasirox Umedica
  • Malta · Deferasirox Pharos
  • Netherlands · Deferasirox Abdi, Deferasirox Amarox
  • Norway · Deferasirox Accord, Deferasirox Medical Valley
  • Poland · Deferasirox Msn, Exferana
  • Portugal · Deferasirox 180 Mg, Deferasirox 360 Mg
  • Romania · Deferasirox Msn Laboratories, Deferasirox Sanexcel
  • Sweden · Deferasirox Glenmark, Deferasirox Jubilant
  • Slovakia · Deferasirox, Deferasirox Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d166ec5c-4d36-425f-bfdf-9281f165f1bc
GET /v1/drugs/d166ec5c-4d36-425f-bfdf-9281f165f1bc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "40917811000001109",
  "desc": "Deferasirox 360mg tablets (Torrent Pharma (UK) Ltd)",
  "form": "Oral tablet",
  "vpid": "33631411000001105",
  "source": "dmd",
  "vtm_id": "775460008",
  "strength": "360 mg",
  "substance": "Deferasirox",
  "ingredient": "Deferasirox",
  "supplier_code": "31535811000001105"
}

See everything about deferasirox.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.